Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole for Bipolar Disorder and Alcohol Use Disorder
NCT02918370Phase 3Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Nov 2016
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in alcohol use disorder (AUD) and bipolar disorder (BD) comparing Aripiprazole with Placebo (2 arms). Primary endpoint: Timeline Followback at 12 weeks. Started Nov 2016; status: completed.
02
Drugs
aripiprazole
03
Conditions
alcohol use disorder (AUD)bipolar disorder (BD)
Beyond the preview
Go deeper on NCT02918370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02918370.